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It has been reported that luteinizing hormone (LH) had thyropropic effect on rat and human thyroid membrane. It
has been known that patients with PCOS have elevated LH levels in comparison to healthy controls.
The goiter prevalence is more common in women than in men regardless of population. The higher incidence of
thyroid diseases in women has been previously attributed to higher estradiol levels. Estradiol has been shown to
enhance proliferative and mitogenic activities of thyroid cells. However, in recent years chronic estradiol treatment
has been shown to reduce volume densities of thyroid follicles, follicular epithelium and thyroid gland volume. It is
thought to be due to LH suppression.
Therefore we suggested that increased LH levels might provide a stimulus for growth on thyroid and alter thyroid
function. Therefore patients with PCOS who had elevated LH levels should be treated by combined estradiol pills
such as estrogen-progestin contraceptives for suppression of LH secretion. Further studies are needed to evaluate
the association between LH, LH suppression and thyroid volume in patients with PCOS.
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Human chorionic gonadotropin (hCG) secreting placen-
tal tumors such as hydatidiform moles and choriocarcin-
omas have been found to be associated with
hyperthyroidism [1] and HCG has been reported to in-
crease TSH receptor expression, thyroid hormone secre-
tion, iodide uptake, organification, adenylate cyclase, and
deoxribonucleic acid synthesis in rat and also cultured
human thyrocytes [2-4].
Luteinizing hormone is a glycoprotein hormone like
TSH and has similar alpha subunit. In Carayon et al.
study LH has been identified to increase thyroid adenyl-
ate cylase activity 65 times more potently than HCG in
human thyroid membranes [5]. Also, in Yoshimura et al.
study human LH has been found to be more potent than
HCG in binding to the TSH receptor and stimulating
adenylate cyclase [6]. As mentioned above, hCG and LH
have thyrotropic effect on rat and human thyroid
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reproduction in any medium, provided the orOur hypotheses is increased LH levels might have a
growth effect on thyroid gland in patients with polycys-
tic ovary syndrome (PCOS). Polycystic ovary syndrome
is a common endocrine disorder affecting at least five to
10% of women of reproductive age [7].
The goiter prevalence is more common in women
than in men regardless of population [8]. However, there
have been no data on increased thyroid volume or goitre
prevalence in women with PCOS versus women with
regular menstrual cycles. The higher incidence of thy-
roid diseases in women has been previously attributed to
higher estradiol levels. Estradiol has been shown to en-
hance proliferative and mitogenic activities of thyroid
cells [9,10]. However, in recent years chronic estradiol
treatment has been shown to reduce volume densities of
thyroid follicles, follicular epithelium and thyroid gland
volume [11,12]. Despite the enhancing effect of estradiol
on thyroid cells, the reducing effect of chronic estradiol
treatment on thyroid volume can be related to LH
suppression.
It has been known that patients with PCOS have ele-
vated LH levels [13,14] and also have higher
gonadotrophin-releasing hormone (GnRH)-stimulated
LH concentrations in comparison to healthy controlsd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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study 3712 women were evaluated and found that oral
contraceptives were related with a lower thyroid volume
and reduced risk of goiter. In this study the oral contra-
ceptives users had goitre four times less common than
non-users [12]. In this case, the LH suppression with
oral contraceptives including estradiol might be the fac-
tor for decreased thyroid volumes consistent with
present hypotheses. However, this literature applies to
general population of women, and not to women with
PCOS and additionally, in literature search there is no
data that the use oral contraceptives in women with
PCOS is associated with reduction of thyroid volume or
lower goitre prevalence.
In the recent hypotheses increased LH levels might
provide a stimulus for growth on thyroid and alter thy-
roid function. Therefore patients with PCOS who had
elevated LH levels should be treated by combined estra-
diol pills such as estrogen-progestin contraceptives for
suppression of LH secretion. Further studies are needed
to evaluate the association between LH, LH suppression
and thyroid volume in patients with PCOS.
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